author-photo

Ritesh Tichkule

Northeastern University

8

Papers

261

Citations

Citation Trend

Filter By

Papers (7) Sort By

Journal Conference Others

Corrigendum to “The novel peripherally active cannabinoid type 1 and serotonin type 3 receptor agonist AM9405 inhibits gastrointestinal motility and reduces abdominal pain in mouse models mimicking irritable bowel syndrome” [Eur. J. Pharmacol. (2018), 836 34–43]

2019 European Journal of Pharmacology
Show All
- Source
- Cite
- Save
Citations (0)
6-Amino-3-methylpyrimidinones as Potent, Selective, and Orally Efficacious SHP2 Inhibitors

2019 Journal of Medicinal Chemistry
Show All
- Source
- Cite
- Save
Citations (36)
The novel peripherally active cannabinoid type 1 and serotonin type 3 receptor agonist AM9405 inhibits gastrointestinal motility and reduces abdominal pain in mouse models mimicking irritable bowel syndrome

2018 European Journal of Pharmacology
Show All
- Source
- Cite
- Save
Citations (6)
Novel Electrophilic and Photoaffinity Covalent Probes for Mapping the Cannabinoid 1 Receptor Allosteric Site(s)

2016 Journal of Medicinal Chemistry
Show All
- Source
- Cite
- Save
Citations (41)
In-vivo pharmacological evaluation of the CB1-receptor allosteric modulator Org-27569

2014 Behavioural Pharmacology
Show All
- Source
- Cite
- Save
Citations (50)
Cannabinoids Alleviate Experimentally Induced Intestinal Inflammation by Acting at Central and Peripheral Receptors

2014 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (50)
Latest advances in cannabinoid receptor agonists.

2009 Expert Opinion on Therapeutic Patents
Show All
- Source
- Cite
- Save
Citations (76)